140 related articles for article (PubMed ID: 4883637)
1. Long-acting and short-acting sulfonamides. Recent developments.
Struller T
Antibiot Chemother; 1968; 14():179-215. PubMed ID: 4883637
[No Abstract] [Full Text] [Related]
2. [Behavior of sulfanilamides in the body].
Reimerdes E; Thumim JH
Arzneimittelforschung; 1970 Sep; 20(9):1171-9. PubMed ID: 4922318
[No Abstract] [Full Text] [Related]
3. [Significance of acid stability of sulfonamides for the determination of their N4-metabolites].
Reimerdes EH; Seydel JK
Arzneimittelforschung; 1969 Nov; 19(11):1863-8. PubMed ID: 5395657
[No Abstract] [Full Text] [Related]
4. IN VITRO SENSITIVITY OF ESCHERICHIA COLI TO SULFONAMIDES.
GLANTZ PJ
Cornell Vet; 1965 Jan; 55():9-18. PubMed ID: 14284453
[No Abstract] [Full Text] [Related]
5. [ANTIBACTERIAL SULFONAMIDES].
TREFOUEL J
Prod Probl Pharm; 1964 Jan; 19():3-14. PubMed ID: 14135919
[No Abstract] [Full Text] [Related]
6. Polymorphism in sulfonamides.
Yang SS; Guillory JK
J Pharm Sci; 1972 Jan; 61(1):26-40. PubMed ID: 5066733
[No Abstract] [Full Text] [Related]
7. Warning against prolonged-action sulfonamides.
Med Lett Drugs Ther; 1966 Feb; 8(4):13-4. PubMed ID: 5907884
[No Abstract] [Full Text] [Related]
8. Characterization of sulfonamides by TLC using metal ions.
Walash MI; Agarwal SP
J Pharm Sci; 1972 Feb; 61(2):277-8. PubMed ID: 5066790
[No Abstract] [Full Text] [Related]
9. Identification of sulfonamides by NMR spectroscopy.
Turczan J; Medwick T
J Pharm Sci; 1972 Mar; 61(3):434-43. PubMed ID: 5066968
[No Abstract] [Full Text] [Related]
10. Absorption of sulphonamides and antitubercular drugs from the rat lung.
Burton JA; Schanker LS
Xenobiotica; 1974 May; 4(5):291-6. PubMed ID: 4407063
[No Abstract] [Full Text] [Related]
11. Clinical pharmacokinetics of sulphonamides and their N4-acetyl derivatives.
Hekster CA; Vree TB
Antibiot Chemother (1971); 1982; 31():22-118. PubMed ID: 7036849
[No Abstract] [Full Text] [Related]
12. Effect of food on absorption of sulfonamides in man.
Macdonald H; Place VA; Falk H; Darken MA
Chemotherapy; 1967; 12(5):282-5. PubMed ID: 6081878
[No Abstract] [Full Text] [Related]
13. [SULFONAMIDES].
BOERGER HH
Ther Ggw; 1963 Sep; 102():1037-44. PubMed ID: 14057434
[No Abstract] [Full Text] [Related]
14. [Comparative study of the blood concentration and urinary excretion of sulfamerazine].
VIOLANTE LATOUR A; HERNANDEZ PERAL G
Analecta Med; 1945; 6(1):27-39. PubMed ID: 21014519
[No Abstract] [Full Text] [Related]
15. [Mechanism of hydrolysis of N4-substituted sulfanilamides in vivo].
Funk KF; Oelssner W
Pharmazie; 1970 Sep; 25(9):557-60. PubMed ID: 4098821
[No Abstract] [Full Text] [Related]
16. Solubility parameter of selected sulfonamides.
Sunwoo C; Eisen H
J Pharm Sci; 1971 Feb; 60(2):238-44. PubMed ID: 5572447
[No Abstract] [Full Text] [Related]
17. [METABOLIC FATE OF DELAYED-ACTION SULFONAMIDES].
SALVI G; PLANCHER AC
Farmaco Prat; 1964 Feb; 19():75-83. PubMed ID: 14138309
[No Abstract] [Full Text] [Related]
18. Unusual cell form of Bacterium anitratum produced by sulfonamides.
Brzin B
Experientia; 1966 Mar; 22(3):149-50. PubMed ID: 5959919
[No Abstract] [Full Text] [Related]
19. [CONTRIBUTION ON PAPER CHROMATOGRAPHY OF SULFONAMIDES].
MACEK K
Cesk Farm; 1963 Sep; 12():365-6. PubMed ID: 14092128
[No Abstract] [Full Text] [Related]
20. [On the protein-binding of long-acting sulfonamides].
SCHOLTAN W
Chemotherapia (Basel); 1963; 6():180-95. PubMed ID: 13992327
[No Abstract] [Full Text] [Related]
[Next] [New Search]
